Free Trial

The Cigna Group (CI) Competitors

$338.04
+0.13 (+0.04%)
(As of 06/7/2024 ET)

CI vs. ELV, HUM, CNC, MOH, UNH, OSCR, ALHC, TRUP, CLOV, and NEUE

Should you be buying The Cigna Group stock or one of its competitors? The main competitors of The Cigna Group include Elevance Health (ELV), Humana (HUM), Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Oscar Health (OSCR), Alignment Healthcare (ALHC), Trupanion (TRUP), Clover Health Investments (CLOV), and NeueHealth (NEUE). These companies are all part of the "hospital & medical service plans" industry.

The Cigna Group vs.

Elevance Health (NYSE:ELV) and The Cigna Group (NYSE:CI) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Elevance Health has a net margin of 3.64% compared to Elevance Health's net margin of 1.76%. The Cigna Group's return on equity of 20.62% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health3.64% 20.62% 7.35%
The Cigna Group 1.76%17.24%5.09%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.0% of The Cigna Group shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by insiders. Comparatively, 0.6% of The Cigna Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Elevance Health has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, The Cigna Group has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500.

The Cigna Group received 94 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 71.95% of users gave The Cigna Group an outperform vote while only 66.80% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
Elevance HealthOutperform Votes
837
66.80%
Underperform Votes
416
33.20%
The Cigna GroupOutperform Votes
931
71.95%
Underperform Votes
363
28.05%

Elevance Health currently has a consensus price target of $601.64, suggesting a potential upside of 11.63%. The Cigna Group has a consensus price target of $373.87, suggesting a potential upside of 10.60%. Given The Cigna Group's higher possible upside, equities research analysts clearly believe Elevance Health is more favorable than The Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
3.00
The Cigna Group
0 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
3.00

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. The Cigna Group pays an annual dividend of $5.60 per share and has a dividend yield of 1.7%. Elevance Health pays out 24.6% of its earnings in the form of a dividend. The Cigna Group pays out 46.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years and The Cigna Group has increased its dividend for 4 consecutive years.

Elevance Health has higher earnings, but lower revenue than The Cigna Group. Elevance Health is trading at a lower price-to-earnings ratio than The Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$171.75B0.73$5.99B$26.4620.37
The Cigna Group$195.27B0.49$5.16B$12.1827.75

In the previous week, Elevance Health had 1 more articles in the media than The Cigna Group. MarketBeat recorded 17 mentions for Elevance Health and 16 mentions for The Cigna Group. The Cigna Group's average media sentiment score of 1.01 beat Elevance Health's score of 0.97 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
8 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
The Cigna Group
8 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Elevance Health beats The Cigna Group on 14 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CI vs. The Competition

MetricThe Cigna GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$96.03B$64.88B$5.19B$17.64B
Dividend Yield1.68%1.34%2.73%3.54%
P/E Ratio27.7521.78169.7525.56
Price / Sales0.490.552,430.3914.08
Price / Cash9.3310.0635.0919.71
Price / Book2.143.964.964.99
Net Income$5.16B$3.04B$110.27M$975.33M
7 Day Performance-1.86%-2.35%-0.96%-1.87%
1 Month Performance-2.50%3.06%-1.11%-0.76%
1 Year Performance29.13%14.42%-1.96%8.57%

The Cigna Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.7492 of 5 stars
$538.97
-0.4%
$601.64
+11.6%
+17.1%$125.27B$171.75B20.37104,900Analyst Forecast
Positive News
HUM
Humana
4.8263 of 5 stars
$351.80
-1.0%
$423.63
+20.4%
-30.3%$42.39B$109.24B21.9167,600Analyst Revision
CNC
Centene
4.8591 of 5 stars
$69.81
-0.9%
$84.93
+21.7%
+3.1%$37.25B$154.00B13.8867,700
MOH
Molina Healthcare
4.9823 of 5 stars
$309.56
-1.2%
$407.45
+31.6%
+9.0%$18.37B$34.07B16.80123,123
UNH
UnitedHealth Group
4.938 of 5 stars
$490.52
-2.3%
$578.75
+18.0%
+1.7%$461.96B$371.62B29.98440,000Dividend Increase
Analyst Upgrade
OSCR
Oscar Health
2.6764 of 5 stars
$19.35
-0.8%
$18.57
-4.0%
+117.4%$4.63B$5.86B-48.362,400Insider Selling
High Trading Volume
ALHC
Alignment Healthcare
2.692 of 5 stars
$8.34
-0.6%
$9.20
+10.3%
+25.2%$1.59B$1.82B-9.931,536
TRUP
Trupanion
2.3023 of 5 stars
$27.91
-5.8%
$32.80
+17.5%
+23.0%$1.24B$1.11B-43.611,142Gap Down
CLOV
Clover Health Investments
1.6472 of 5 stars
$1.10
flat
$1.50
+36.4%
+10.0%$546.08M$2.06B-3.24552
NEUE
NeueHealth
1.3973 of 5 stars
$5.55
-4.3%
$8.00
+44.1%
N/A$45.62M$1.16B-0.041,252Negative News
Gap Down

Related Companies and Tools

This page (NYSE:CI) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners